Global and India Buprenorphine Hydrochloride Market Insights, Forecast to 2027

Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.

Market Analysis and Insights: Global and India Buprenorphine Hydrochloride Market
This report focuses on global and India Buprenorphine Hydrochloride market.
In 2020, the global Buprenorphine Hydrochloride market size was US$ 136.1 million and it is expected to reach US$ 155.1 million by the end of 2027, with a CAGR of 1.9% during 2021-2027. In India the Buprenorphine Hydrochloride market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Buprenorphine Hydrochloride Scope and Market Size
Buprenorphine Hydrochloride market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Buprenorphine Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For India market, this report focuses on the Buprenorphine Hydrochloride market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in India.

Segment by Type
Tablets
Injection

Segment by Application
Analgesic
Opioid Antagonist

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi